Shopping Cart
- Remove All
- Your shopping cart is currently empty
BBO-8520 is an orally available direct small molecule covalent inhibitor that targets KRAS G12C. It functions as a KRAS G12C (OFF) inhibitor and blocks the KRAS G12C (ON) signal by binding to the GTP protein, thereby inhibiting cell proliferation. Additionally, BBO-8520 can disrupt the RAS-RAF1 interaction, returning KRAS G12C to its inactive (OFF) state [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | BBO-8520 is an orally available direct small molecule covalent inhibitor that targets KRAS G12C. It functions as a KRAS G12C (OFF) inhibitor and blocks the KRAS G12C (ON) signal by binding to the GTP protein, thereby inhibiting cell proliferation. Additionally, BBO-8520 can disrupt the RAS-RAF1 interaction, returning KRAS G12C to its inactive (OFF) state [1]. |
In vivo | BBO-8520 (10 mg/kg/d; po) inhibits pERK and KRAS G12C activation in the KrasG12C-p53 driven GEMM model, resulting in sustained tumor regression. Additionally, BBO-8520 demonstrates a strong dose- and time-dependent pharmacodynamic effect in KRASG12C mutant tumor-bearing mice, with pERK inhibition exceeding 80% [1]. |
Molecular Weight | 729.74 |
Formula | C35H33F6N7O2S |
Cas No. | 2893809-51-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.